Intercept Pharma upgraded by Canaccord Genuity with a new price target

6/29/23 7:24:17 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Canaccord Genuity upgraded Intercept Pharma from Hold to Buy and set a new price target of $18.00 from $12.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ICPT

Date	Price Target	Rating	Analyst
7/13/2023	$8.00 → $19.00	Sell → Buy	H.C. Wainwright
6/29/2023	$12.00 → $18.00	Hold → Buy	Canaccord Genuity
5/23/2023		Buy → Hold	Needham
5/22/2023	$8.00	Neutral → Sell	H.C. Wainwright
5/17/2023		Outperform → Mkt Perform	Raymond James
3/8/2022	$31.00 → $29.00	Hold	Canaccord Genuity
3/3/2022	$22.00 → $16.00	Sector Perform	RBC Capital
3/3/2022	$30.00 → $25.00	Buy	Needham